An HLA-DR-degenerate epitope pool detects insulin-like growth factor binding protein 2-specific immunity in patients with cancer.
about
Targeted immune therapy of ovarian cancerA degenerate HLA-DR epitope pool of HER-2/neu reveals a novel in vivo immunodominant epitope, HER-2/neu88-102.Identification of prostatic acid phosphatase (PAP) specific HLA-DR1-restricted T-cell epitopes.Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancerImmunity and immune suppression in human ovarian cancer.Therapeutic cancer vaccines and translating vaccinomics science to the global health clinic: emerging applications toward proof of conceptOncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer.Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigen.Identification of HLA-DRB1*09:01-restricted Mycobacterium tuberculosis CD4+ T-cell epitopes.Elevated serum antibodies against insulin-like growth factor-binding protein-2 allow detecting early-stage cancers: evidences from glioma and colorectal carcinoma studies.
P2860
Q28082828-3D2696B0-69AF-4F5F-B71C-3A22A365835EQ33638509-1838B73C-E337-46DA-AC4F-0D1105CCA14FQ34243390-713C2756-3D3F-431F-89D0-F5DCA1F332EBQ35032491-C8CAB396-D717-4771-B173-FC43EF186C40Q35138135-136EA009-6C1D-4853-9593-5B383C1976B9Q35193892-6A92FEC9-6526-4EF8-AF18-0C032F9CFE6EQ35226511-E93CFE35-78AE-4DB0-8D68-F551116CD86DQ36886232-3D6F255F-D728-40E2-8CFD-1C2FA8FD7C33Q47850403-BFAD2A31-9334-40FC-A29A-4305F71EFEB1Q55462258-B5412DEE-11FC-4C49-B819-738FB1C2ECFF
P2860
An HLA-DR-degenerate epitope pool detects insulin-like growth factor binding protein 2-specific immunity in patients with cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
An HLA-DR-degenerate epitope p ...... unity in patients with cancer.
@en
An HLA-DR-degenerate epitope p ...... unity in patients with cancer.
@nl
type
label
An HLA-DR-degenerate epitope p ...... unity in patients with cancer.
@en
An HLA-DR-degenerate epitope p ...... unity in patients with cancer.
@nl
prefLabel
An HLA-DR-degenerate epitope p ...... unity in patients with cancer.
@en
An HLA-DR-degenerate epitope p ...... unity in patients with cancer.
@nl
P2093
P2860
P1433
P1476
An HLA-DR-degenerate epitope p ...... munity in patients with cancer
@en
P2093
Christopher J Krco
Courtney L Erskine
Elliot M Johnson
Glenn Ishioka
John D Fikes
Karin Goodman
Keith L Knutson
Kimberly R Kalli
Lynn C Hartmann
P2860
P304
P356
10.1158/0008-5472.CAN-07-6726
P407
P577
2008-06-01T00:00:00Z